SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001638287-18-000019
Filing Date
2018-05-08
Accepted
2018-05-08 16:04:41
Documents
3
Period of Report
2018-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gemp-20180508x8k.htm 8-K 37096
2 EX-99.1 gemp-20180508ex9918d8185.htm EX-99.1 122966
3 GRAPHIC gemp20180508ex9918d8185001.jpg GRAPHIC 4840
  Complete submission text file 0001638287-18-000019.txt   168052
Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 248-980-6538
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 18814502
SIC: 2834 Pharmaceutical Preparations